LIRALTAGENE AUTOLEUCEL TRANSGENE INSERT
UNII U4HZC9CG3U

Substance Identification & Data

This profile provides standardized clinical and technical data for Liraltagene Autoleucel Transgene Insert, uniquely identified by the FDA Unique Ingredient Identifier (UNII) U4HZC9CG3U.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
U4HZC9CG3U
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
LIRALTAGENE AUTOLEUCEL TRANSGENE INSERT
Official standardized name for this substance within the FDA UNII nomenclature system.
Substance Type
nucleicAcid
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Liraltagene Autoleucel Transgene Insert. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

LIRALTAGENE AUTOLEUCEL TRANSGENE INSERT
LIRALTAGENE AUTOLEUCEL TRANSGENE INSERT ENCODING CODON-OPTIMISED FOLLICLE-STIMULATING HORMONE (FSH) (SUBUNITS FSH.BETA. AND CG.ALPHA., LINKED BY A GLYCINE/SERINE SPACER), PRECEDED BY THE FSH.BETA. SIGNAL PEPTIDE, AND FUSED TO A CD8.ALPHA. HINGE AND TRANSMEMBRANE DOMAIN, A 4-1BB CO-STIMULATORY DOMAIN AND A CD3.ZETA. SIGNALLING DOMAIN, UNDER CONTROL OF THE MOLONEY MURINE LEUKEMIA VIRUS (MMLV) LTR PROMOTER

External Clinical & Regulatory Resources

NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record